论文部分内容阅读
目的 研究经皮植入导管药盒系统 (PCS)在晚期恶性肿瘤治疗中的应用价值。方法 对 5 6例不能手术治疗的晚期恶性肿瘤患者进行经皮导管药盒系统植入术 ,并定期行动脉内灌注化疗或靶血管化疗栓塞治疗。结果 PCS植入成功率 1 0 0 % ,大部分患者临床症状改善 ,肺恶性肿瘤、肝恶性肿瘤、直结肠癌病例中病灶缩小率为 47.4%、82 .7%、62 .5 %。结论 经皮植入导管药盒系统治疗晚期恶性肿瘤为分次栓塞和长期间歇化疗建立了良好的药物投送通道 ,方便实用 ,疗效显著
Objective To investigate the value of percutaneous implantation of catheter kit (PCS) in the treatment of advanced malignancies. Methods Percutaneous catheter kit implantation was performed in 56 patients with advanced malignancies who were not surgically treated. Intravenous chemotherapy or target-vessel chemoembolization was performed on a regular basis. Results The success rate of PCS implantation was 100%. The clinical symptoms of most patients were improved. The shrinkage rates of lung cancer, liver cancer and colorectal cancer were 47.4%, 82.7% and 62.5% respectively. Conclusion Percutaneous implantation of the catheter kit system for the treatment of advanced malignant tumors for grading embolization and long-term intermittent chemotherapy to establish a good drug delivery channel, convenient and practical, significant effect